Skip to content
Search

Latest Stories

NHS Trust signs 10-year deal with tech firm for digital-first integrated care

Royal Wolverhampton NHS Trust and technology company Babylon has announced a 10-year partnership to develop a new ‘Digital-First Integrated Care’ delivery model.

Staff and patients at the Trust will use a single free app, which will connect primary and secondary care.


The app allows patients to access clinical consultations with doctors and specialist nurses, giving them full control of appointment booking and prescriptions. They can also access the ‘Personal Clinical Records’ and see their medical history and lifestyle.

The NHS Trust, which runs three hospitals, expects the app to benefit 300,000 people across Wolverhampton and its surroundings with faster treatments and fewer trips to the hospital.

“As medicine transforms over the next 10 years, and cutting-edge technology improves, it is critical that the NHS develops a digitally empowered workforce. With the Trust’s end-to-end care portfolio this is a huge opportunity for us and Babylon to constructively tackle all of these things together,” said David Loughton, Trust Chief Executive.

“I am confident that this won’t be just good for our patients, it will benefit the wider NHS through early prevention, treatment and the sharing of our learning."

Babylon’s artificial intelligence-underpinned personalised care plans will also offer proactive care of patients with chronic diseases and give users medical information and triage advice.

Ali Parsa, CEO and Founder of Babylon, said: “We have over 1,000 AI experts, clinicians, engineers and scientists who will be helping to make Digital-First Integrated Care a reality and provide fast, effective, proactive care to patients. Together with RWT, we can demonstrate this works and help the NHS lead healthcare across the world”.

The first new services are expected to go live before the end of 2020.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less